{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:20:28Z","timestamp":1791429628989,"version":"4.3.3"},"reference-count":65,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"NIH\/NIA","award":["AG058210"],"award-info":[{"award-number":["AG058210"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Patients with type 2 diabetes (T2D) have reduced bone turnover and increased fractures. Advanced glycation end products (AGEs) impair osteoblasts and are implicated in diabetic fractures. Pyridoxamine (PM) is a vitamin B6 metabolite that inhibits formation of AGEs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We hypothesized that PM treatment in older patients with T2D, by inhibiting AGEs, would increase bone formation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a double-blind randomized controlled trial at an academic center. Older women with T2D were included (n = 55). Oral PM 200\u2005mg twice daily for 1 year was given. The primary outcome was the change in the bone formation marker P1NP. Other outcomes were changes in bone resorption, bone mineral density (BMD), HbA1c, and skin autofluorescence (SAF), and in a bone biopsy subgroup, the correlation between bone fluorescent AGEs (fAGEs) and SAF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>P1NP increased 23.0% with PM (95% CI 9, 37; within group P = .028) vs 4.1% with placebo (\u22129, 17; within group P = .576; between groups P = .056). BMD increased at the femoral neck (PM 2.6 \u00b1 5% vs placebo \u22120.9 \u00b1 4%; between groups P = .007). Bone resorption markers and SAF did not change. HbA1c decreased (PM \u22120.38 \u00b1 0.7% vs placebo 0.05 \u00b1 1.7%; between groups P = .04). Within the PM group, the HbA1c change correlated inversely with the % P1NP change (r = \u22120.50, P = .034). Cortical bone biopsy fAGEs correlated with SAF (r = 0.86, P = .001). Adverse events were similar between groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PM tended to increase P1NP in older women with T2D, as well as increasing bone density and reducing HbA1c. Further studies are needed to investigate the potential of PM as a disease mechanism\u2013directed approach to reduce fractures in T2D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae700","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:35:26Z","timestamp":1728369326000},"page":"961-972","source":"Crossref","is-referenced-by-count":3,"title":["The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial"],"prefix":"10.1210","volume":"110","author":[{"given":"Aiden V","family":"Brossfield","sequence":"first","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J","family":"McMahon","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Fernando","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Omeragic","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukshana","family":"Majeed","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-0717","authenticated-orcid":false,"given":"Sanchita","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna E","family":"Sroga","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Shirley Ann Jackson, PhD Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute , Troy, NY 12180 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0049-1623","authenticated-orcid":false,"given":"Bowen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Shirley Ann Jackson, PhD Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute , Troy, NY 12180 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-0167","authenticated-orcid":false,"given":"Deepak","family":"Vashishth","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Shirley Ann Jackson, PhD Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute , Troy, NY 12180 ,","place":["USA"]},{"name":"Rensselaer-Icahn School of Medicine Center for Engineering and Precision Medicine , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-2121","authenticated-orcid":false,"given":"Mishaela R","family":"Rubin","sequence":"additional","affiliation":[{"name":"Metabolic Bone Disease Unit, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"2025031717042960900_dgae700-B1","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"issue":"9","key":"2025031717042960900_dgae700-B2","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00198-017-4096-y","article-title":"Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study","volume":"28","author":"Martinez-Laguna","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"2025031717042960900_dgae700-B3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"issue":"9","key":"2025031717042960900_dgae700-B4","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","article-title":"Risk of fracture in women with type 2 diabetes: the Women\u2019s Health Initiative Observational Study","volume":"91","author":"Bonds","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025031717042960900_dgae700-B5","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"MECHANISMS IN ENDOCRINOLOGY: diabetes mellitus, a state of low bone turnover\u2014a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025031717042960900_dgae700-B6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2025031717042960900_dgae700-B7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced Glycation End Products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025031717042960900_dgae700-B8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1433.044","article-title":"Pentosidine effects on human osteoblasts in vitro","volume":"1126","author":"Sanguineti","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2025031717042960900_dgae700-B9","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgab027","article-title":"Investigation of mechanical, material, and compositional determinants of human trabecular bone quality in type 2 diabetes","volume":"106","author":"Sihota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025031717042960900_dgae700-B10","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes","volume":"94","author":"Schwartz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"47","key":"2025031717042960900_dgae700-B11","doi-asserted-by":"crossref","first-page":"46616","DOI":"10.1074\/jbc.M307155200","article-title":"Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions","volume":"278","author":"Voziyan","year":"2003","journal-title":"J Biol Chem"},{"issue":"8","key":"2025031717042960900_dgae700-B12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-004-1474-8","article-title":"Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat","volume":"47","author":"Alderson","year":"2004","journal-title":"Diabetologia"},{"issue":"6","key":"2025031717042960900_dgae700-B13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am J Nephrol"},{"issue":"1","key":"2025031717042960900_dgae700-B14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1302\/2046-3758.71.BJR-2017-0135.R1","article-title":"The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone","volume":"7","author":"Abar","year":"2018","journal-title":"Bone Joint Res"},{"issue":"1","key":"2025031717042960900_dgae700-B15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2011030272","article-title":"Pyridorin in type 2 diabetic nephropathy","volume":"23","author":"Lewis","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2025031717042960900_dgae700-B16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"9","author":"Schulz","year":"2011","journal-title":"Int J Surg"},{"issue":"8","key":"2025031717042960900_dgae700-B17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jbmr.5650090817","article-title":"Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women","volume":"9","author":"Kleerekoper","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025031717042960900_dgae700-B18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1359\/jbmr.1997.12.4.498","article-title":"Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss","volume":"12","author":"Han","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025031717042960900_dgae700-B19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2143(98)90109-3","article-title":"Biochemical and hormonal variables in black and white women matched for age and weight","volume":"132","author":"Aloia","year":"1998","journal-title":"J Lab Clin Med"},{"issue":"10","key":"2025031717042960900_dgae700-B20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.4417","article-title":"Racial and ethnic disparities in bone health and outcomes in the United States","volume":"36","author":"Noel","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025031717042960900_dgae700-B21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00198-017-3996-1","article-title":"Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014","volume":"28","author":"Looker","year":"2017","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025031717042960900_dgae700-B22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1359\/JBMR.041007","article-title":"Osteoporosis and fracture risk in women of different ethnic groups","volume":"20","author":"Barrett-Connor","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025031717042960900_dgae700-B23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025031717042960900_dgae700-B24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM198308253090801","article-title":"Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome","volume":"309","author":"Schaumburg","year":"1983","journal-title":"N Engl J Med"},{"key":"2025031717042960900_dgae700-B25","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/jbmr.4096","article-title":"Skin autofluorescence, a noninvasive biomarker for advanced glycation end-products, is associated with prevalent vertebral and major osteoporotic fractures: the Rotterdam study","volume":"35","author":"Waqas","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025031717042960900_dgae700-B26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"issue":"6","key":"2025031717042960900_dgae700-B27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"issue":"14","key":"2025031717042960900_dgae700-B28","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1364\/OE.18.014416","article-title":"Skin color independent assessment of aging using skin autofluorescence","volume":"18","author":"Koetsier","year":"2010","journal-title":"Opt Express"},{"issue":"9","key":"2025031717042960900_dgae700-B29","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00198-013-2319-4","article-title":"Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone","volume":"24","author":"Karim","year":"2013","journal-title":"Osteoporos Int"},{"issue":"6","key":"2025031717042960900_dgae700-B30","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1210\/jc.2016-1437","article-title":"Advanced glycation endproducts and bone material strength in type 2 diabetes","volume":"101","author":"Furst","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025031717042960900_dgae700-B31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmbbm.2015.08.012","article-title":"A direct role of collagen glycation in bone fracture","volume":"52","author":"Poundarik","year":"2015","journal-title":"J Mech Behav Biomed Mater"},{"key":"2025031717042960900_dgae700-B32","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgab027","article-title":"Investigation of mechanical, material and compositional determinants of human trabecular bone quality in type 2 diabetes","volume":"106","author":"Sihota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025031717042960900_dgae700-B33","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jbmr.3711","article-title":"Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men with type 2 diabetes mellitus","volume":"34","author":"Hunt","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025031717042960900_dgae700-B34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025031717042960900_dgae700-B35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbmr.4466","article-title":"Greater carboxy-methyl-lysine is associated with increased fracture risk in type 2 diabetes","volume":"37","author":"Dhaliwal","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025031717042960900_dgae700-B36","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1074\/jbc.M109935200","article-title":"A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation","volume":"277","author":"Voziyan","year":"2002","journal-title":"J Biol Chem"},{"issue":"7","key":"2025031717042960900_dgae700-B37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.freeradbiomed.2007.09.016","article-title":"Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine","volume":"44","author":"Chetyrkin","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2025031717042960900_dgae700-B38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.abb.2003.08.021","article-title":"Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications","volume":"419","author":"Metz","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"2025031717042960900_dgae700-B39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1523-1755.2005.00531.x","article-title":"Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats","volume":"68","author":"Kakuta","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"2025031717042960900_dgae700-B40","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/dom.14977","article-title":"Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: a randomized double-blind placebo-controlled trial","volume":"25","author":"Van den Eynde","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"2025031717042960900_dgae700-B41","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1210\/jc.2012-1546","article-title":"Circulating osteogenic precursor cells in type 2 diabetes mellitus","volume":"97","author":"Manavalan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025031717042960900_dgae700-B42","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2025031717042960900_dgae700-B43","doi-asserted-by":"crossref","first-page":"116880","DOI":"10.1016\/j.bone.2023.116880","article-title":"Advanced glycation and glycoxidation end products in bone","volume":"176","author":"Wang","year":"2023","journal-title":"Bone"},{"issue":"1","key":"2025031717042960900_dgae700-B44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11657-020-00804-6","article-title":"Association between diabetic neuropathy and osteoporosis in patients: a systematic review and meta-analysis","volume":"15","author":"Liu","year":"2020","journal-title":"Arch Osteoporos"},{"issue":"7","key":"2025031717042960900_dgae700-B45","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"issue":"2","key":"2025031717042960900_dgae700-B46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jbmr.4757","article-title":"Increased advanced glycation endproducts, stiffness, and hardness in iliac crest bone from postmenopausal women with type 2 diabetes mellitus on insulin","volume":"38","author":"Lekkala","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025031717042960900_dgae700-B47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jdiacomp.2009.05.002","article-title":"Metformin reverses the deleterious effects of high glucose on osteoblast function","volume":"24","author":"Zhen","year":"2010","journal-title":"J Diabetes Complications"},{"issue":"6","key":"2025031717042960900_dgae700-B48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00592-015-0792-2","article-title":"Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes","volume":"52","author":"Li","year":"2015","journal-title":"Acta Diabetol"},{"key":"2025031717042960900_dgae700-B49","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1210\/clinem\/dgad255","article-title":"Biochemical markers of bone fragility in patients with diabetes. A narrative review by the IOF and the ECTS","volume":"108","author":"Meier","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025031717042960900_dgae700-B50","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1074\/jbc.M610536200","article-title":"Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation","volume":"282","author":"Valcourt","year":"2007","journal-title":"J Biol Chem"},{"key":"2025031717042960900_dgae700-B51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bone.2019.04.012","article-title":"Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice","volume":"124","author":"Davis","year":"2019","journal-title":"Bone"},{"issue":"50","key":"2025031717042960900_dgae700-B52","doi-asserted-by":"crossref","first-page":"39027","DOI":"10.1074\/jbc.M006700200","article-title":"Effect of collagen turnover on the accumulation of advanced glycation end products","volume":"275","author":"Verzijl","year":"2000","journal-title":"J Biol Chem"},{"key":"2025031717042960900_dgae700-B53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2018.01.028","article-title":"Accumulation of carboxymethyl-lysine (CML) in human cortical bone","volume":"110","author":"Thomas","year":"2018","journal-title":"Bone"},{"issue":"2","key":"2025031717042960900_dgae700-B54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.metabol.2006.08.026","article-title":"Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)\/Ta mice","volume":"56","author":"Tanimoto","year":"2007","journal-title":"Metabolism"},{"issue":"7","key":"2025031717042960900_dgae700-B55","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.38.7.881","article-title":"Erythrocyte O2 transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus","volume":"38","author":"Solomon","year":"1989","journal-title":"Diabetes"},{"issue":"3","key":"2025031717042960900_dgae700-B56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/nu10030285","article-title":"The postprandial anti-hyperglycemic effect of pyridoxine and its derivatives using in vitro and in vivo animal models","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"2025031717042960900_dgae700-B57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12891-019-3011-4","article-title":"Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone","volume":"20","author":"Kida","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"2025031717042960900_dgae700-B58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000489672","article-title":"Cortical or trabecular bone: what's the difference?","volume":"47","author":"Ott","year":"2018","journal-title":"Am J Nephrol"},{"key":"2025031717042960900_dgae700-B59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2018.05.030","article-title":"Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes","volume":"114","author":"Karim","year":"2018","journal-title":"Bone"},{"key":"2025031717042960900_dgae700-B60","doi-asserted-by":"crossref","first-page":"115556","DOI":"10.1016\/j.bone.2020.115556","article-title":"Individuals with type 2 diabetes mellitus show dimorphic and heterogeneous patterns of loss in femoral bone quality","volume":"140","author":"Wolfel","year":"2020","journal-title":"Bone"},{"key":"2025031717042960900_dgae700-B61","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0960327116661023","article-title":"A 7-day intravenous toxicity study and neurotoxicity assessment of pyridorin in Sprague-Dawley rats","volume":"36","author":"Sullivan","year":"2016","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"2025031717042960900_dgae700-B62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12891-016-1168-7","article-title":"Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis","volume":"17","author":"Vaculik","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"2025031717042960900_dgae700-B63","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1359\/JBMR.040311","article-title":"Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study","volume":"19","author":"Strotmeyer","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"23","key":"2025031717042960900_dgae700-B64","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1001\/jama.1992.03490230063029","article-title":"Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus","volume":"268","author":"Barrett-Connor","year":"1992","journal-title":"JAMA"},{"issue":"4","key":"2025031717042960900_dgae700-B65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1359\/JBMR.041219","article-title":"Diabetes and bone loss at the hip in older black and white adults","volume":"20","author":"Schwartz","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae700\/60454207\/dgae700.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/961\/60454207\/dgae700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/961\/60454207\/dgae700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:05:00Z","timestamp":1742231100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/961\/7815469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,8]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae700","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,10,8]]}}}